Sign in

CIK 0001410098

  • Non-accelerated filer

CorMedix Inc.

Sign in to watch
Ticker
CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 908-517-9500
Business address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
  1. 4 Shares withheld for taxes Chief Executive Officer gave up 40,082 shares (to pay taxes)
  2. 4 Grant or award Chief Commercial Officer acquired 133,156 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  5. 4 Shares withheld for taxes Chief Operating Officer gave up 10,895 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Legal Officer gave up 11,333 shares (to pay taxes)
  7. 4 Planned sale Director sold 20,000 shares at $13.00 ($260,000)
  8. 4 Planned sale Chief Executive Officer sold 30,000 shares at $12.00 ($360,000)
  9. 4 Planned sale Director sold 34,000 shares at $12.00 ($408,000)
  10. 4 Open-market sale Director sold 40,000 shares at $11.88 ($475,200)
  11. 4 Planned sale Director sold 46,657 shares at $10.00 ($466,570)
  12. 4 Open-market sale Director sold 26,343 shares at $9.93 ($261,586)
  13. 4 Open-market sale Director sold 30,000 shares at $11.42 ($342,600)
  14. 4 Open-market buy Director bought 25,000 shares at $11.02 ($275,500)
  15. 4 Exercise or conversion Director acquired 13,333 shares (option exercise)
  16. 4 Open-market sale Director sold 10,000 shares at $13.13 ($131,300)
  17. 4 Open-market sale Chief Executive Officer sold 50,000 shares at $13.00 ($650,000)
  18. 4 Shares withheld for taxes Chief Executive Officer gave up 21,225 shares (to pay taxes)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale Chief Legal Officer sold 50,000 shares at an average $13.41 ($670,264)

Page 2 of 26 · 512 filings